Bacillus Clausii for Respiratory Health

Research suggests a possible indirect connection between gut bacteria and respiratory immune responses, including those relevant to viral infections like COVID-19, though direct evidence specifically for Bacillus clausii and respiratory health is limited in the available literature. The single study identified here is a preclinical and observational investigation — not a randomized controlled trial — that found commensal gut bacteria may stimulate antibodies that cross-react with the SARS-CoV-2 spike protein, and that higher levels of these pre-existing antibodies were associated with stronger post-vaccination immune responses in both mice and humans. While this points to an interesting gut-immune axis with potential respiratory implications, the research does not specifically examine Bacillus clausii, and the findings should be interpreted cautiously given the early-stage, non-clinical nature of much of the work. Overall, the evidence base here is too narrow and indirect to draw firm conclusions about Bacillus clausii as a specific intervention for respiratory health.